Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin for post-stroke lower limb spasticity
2007-003817-15Phase 2Completed
- Sponsor
- ASL CN1
- Start
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in Muscle spasm, sponsored by ASL CN1. Primary endpoints: Spasticity of ankle plantar flexors and Spasticity of ankle/foot invertors. Started Nov 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on 2007-003817-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003817-15.